Results 11 to 20 of about 899,405 (297)

Intravenous Immunoglobulins in a Series of 32 Rare and Recalcitrant Immune Dermatoses

Acta Dermato-Venereologica, 2020
Intravenous immunoglobulins are an effective and well-tolerated treatment option for immune dermatological diseases. However, they are primarily used to treat diseases with a severe course and are mostly used off-label.
Roberta Scarpone, Katharina Meier, Kamran Ghoreschi, Margitta Worm   +3 more
doaj   +2 more sources

Hashimoto's encephalopathy: A long-lasting remission induced by intravenous immunoglobulins [PDF]

Vojnosanitetski Pregled, 2011
Background. Hashimoto's encephalopathy (HE) is a rare autoimmune syndrome characterized by various neuropsychiatric manifestations, responsive to steroid treatment and associated with Hashimoto's thyroiditis.
Drulović Jelena, Andrejević Slađana, Bonači-Nikolić Branka, Mijailović Vesna   +3 more
doaj   +2 more sources

Intravenous Immunoglobulins at the Crossroad of Autoimmunity and Viral Infections. [PDF]

Microorganisms, 2021
Intravenous immunoglobulins (IVIG) are blood preparations pooled from the plasma of donors that have been first employed as replacement therapy in immunodeficiency.
Perricone C, Triggianese P, Bursi R, Cafaro G, Bartoloni E, Chimenti MS, Gerli R, Perricone R.   +7 more
europepmc   +2 more sources

Hemolysis related to intravenous immunoglobulins is dependent on the presence of anti‐blood group A and B antibodies and individual susceptibility [PDF]

Transfusion, 2017
Patients treated with intravenous immunoglobulins (IVIG) rarely experience symptomatic hemolysis. Although anti‐A and anti‐B isoagglutinins from the product are involved in most cases, the actual mechanisms triggering hemolysis are unclear.
Orell Mielke, Stefano Fontana, Vesselina Goranova‐Marinova, Amgad Shebl, M. Spycher, Sandra Wymann, Billie L. Durn, John Philip Lawo, Alphonse Hubsch, Abdulgabar Salama   +9 more
openalex   +2 more sources

Use of Intravenous Immunoglobulins in Sepsis Therapy-A Clinical View. [PDF]

Int J Mol Sci, 2020
Sepsis is a life-threatening organ dysfunction, defined by a dysregulated host immune response to infection. During sepsis, the finely tuned system of immunity, inflammation and anti-inflammation is disturbed in a variety of ways.
Jarczak D, Kluge S, Nierhaus A.
europepmc   +2 more sources

Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children.

Journal of the American Medical Association (JAMA), 2021
Importance Multisystem inflammatory syndrome in children (MIS-C) is the most severe pediatric disease associated with severe acute respiratory syndrome coronavirus 2 infection, potentially life-threatening, but the optimal therapeutic strategy remains ...
N. Ouldali, J. Toubiana, D. Antona, E. Javouhey, F. Madhi, M. Lorrot, P. Léger, C. Galeotti, C. Claude, A. Wiedemann, Noémie Lachaume, C. Ovaert, Morgane Dumortier, J. Kahn, A. Mandelcwajg, Lucas Percheron, B. Biot, Jeanne Bordet, Marie Girardin, D. Yang, M. Grimaud, M. Oualha, S. Allali, F. Bajolle, C. Beyler, U. Meinzer, M. Levy, A. Paulet, C. Levy, R. Cohen, A. Belot, F. Angoulvant   +31 more
semanticscholar   +1 more source

Efficacy and safety of intravenous immunoglobulins for the treatment of viral encephalitis: a systematic literature review

Journal of Neurology, 2021
For most viral encephalitides, therapy is merely supportive. Intravenous immunoglobulins (IVIG) have been used as a prophylactic and therapeutic approach. We conduct a systematic review on the safety and efficacy of IVIG in viral encephalitis.
J. Wagner, A. Leibetseder, Anna Troescher, J. Panholzer, T. V. von Oertzen   +4 more
semanticscholar   +1 more source

Primary vs. Secondary Antibody Deficiency: Clinical Features and Infection Outcomes of Immunoglobulin Replacement [PDF]

, 2014
Secondary antibody deficiency can occur as a result of haematological malignancies or certain medications, but not much is known about the clinical and immunological features of this group of patients as a whole. Here we describe a cohort of 167 patients
AA Bousfiha, B Gathmann, B Gathmann, B Piqueras, B Seymour, C Casulo, C Wehr, DF Florescu, E Becerra, E Castigli, ES Resnick, FA Bonilla, G Gunther, H Chapel, H Chapel, H Griffiths, Hilary J. Longhurst, HM Chapel, I De La Torre, I Quinti, J Blore, J Shortt, JA Freeman, JD Edgar, John Dempster, JS Orange, JS Orange, K Warnatz, K Warnatz, L Mouthon, Lorena Lorenzo, M Lucas, M Makatsori, M Yomota, Matthaios Speletas, Matthew Buckland, ME Conley, ME Rose, MJ Boumans, N Ozaras, N Venhoff, NH Yip, P Bright, P McLaughlin, P Wood, R Herriot, S Baris, S Bernatsky, S Molica, Sai S. Duraisingham, Sofia Grigoriadou, SS Duraisingham, T Kawano, U Salzer, W Al-Herz, W Strober   +55 more
core   +6 more sources

Immune-mediated necrotizing myopathy which showed deposition of C5b-9 in the necrotic muscle fibers and was successfully treated with intensive combined therapy with high-dose glucocorticoids, tacrolimus, and intravenous immunoglobulins

Immunological Medicine, 2022
Currently, no standard treatment strategy has been established for immune-mediated necrotizing myopathy (IMNM). Here we present a case of IMNM which was successfully treated with intensive combined therapy with high-dose glucocorticoids, tacrolimus, and ...
Tatsuya Shimada, Misako Higashida-Konishi, Mitsuhiro Akiyama, Satoshi Hama, Keisuke Izumi, Shiro Matsubara, Hisaji Oshima, Yutaka Okano   +7 more
doaj   +1 more source

Comparison of serum immunoglobulin G half-life in dairy calves fed colostrum, colostrum replacer or administered with intravenous bovine plasma. [PDF]

, 2014
In calves, passive immunity of immunoglobulins can be acquired through ingestion of colostrum or colostrum replacers. Plasma can been used to supplement immunoglobulins in healthy or sick calves.
Chigerwe, Munashe, Hagey, Jill V, Murphy, Jacob M   +2 more
core   +1 more source